Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator
暂无分享,去创建一个
Mark Kremers | Warren Smith | Michael R. Gold | M. Gold | B. Knight | R. Weiss | A. León | I. Crozier | J. Herre | M. Burke | Ian Crozier | Warren M. Smith | M. Kremers | M. Hood | Kerry L Lee | Kerry L. Lee | Martin C. Burke | Angel R. Leon | Raul Weiss | M. Rashtian | Mayer Rashtian | Margaret Hood | John M. Herre | Bradley P. Knight
[1] P. Heidenreich,et al. Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study , 2010, Circulation.
[2] V L Gott,et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. , 1980, The New England journal of medicine.
[3] K. Anstrom,et al. Long-term Follow-up in the Sudden Cardiac Death Heart Failure Trial (SCD-HEFT) , 2012 .
[4] Wojciech Zareba,et al. Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.
[5] C. Ervin,et al. Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. , 2010, Journal of the American College of Cardiology.
[6] Analysis of electrocardiograms for subcutaneous monitors. , 2003, Journal of electrocardiology.
[7] R. Tieleman,et al. Is Surface ECG a Useful Surrogate for Subcutaneous ECG? , 2010, Pacing and clinical electrophysiology : PACE.
[8] L. Eckardt,et al. Shock efficacy of the subcutaneous ICD for prevention of sudden cardiac death: Initial multicenter experience , 2013 .
[9] G. Mairesse,et al. The usefulness of surface 12-lead electrocardiogram to predict intra-atrial conduction block after successful atrial flutter ablation. , 2003, Journal of electrocardiology.
[10] B. Wilkoff,et al. How to treat and identify device infections. , 2007, Heart rhythm.
[11] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[12] Alexander H Maass,et al. An entirely subcutaneous implantable cardioverter-defibrillator. , 2010, The New England journal of medicine.
[13] S. Shkurovich,et al. Implantable cardioverter-defibrillator prescription in the elderly. , 2009, Heart rhythm.
[14] C. Israel,et al. Electrical Storm in Patients with an Implanted Defibrillator: A Matter of Definition , 2007, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[15] Thomas Kleemann,et al. Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years , 2007, Circulation.
[16] M. Keller,et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.
[17] N Engl,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.
[18] Stephen L Moore,et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. , 2008, Journal of the American College of Cardiology.
[19] B. Wilkoff,et al. Differences in Tachyarrhythmia Detection and Implantable Cardioverter Defibrillator Therapy by Primary or Secondary Prevention Indication in Cardiac Resynchronization Therapy Patients , 2004, Journal of cardiovascular electrophysiology.
[20] D. Cohen,et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. , 2006, Journal of the American College of Cardiology.
[21] M. Gold,et al. Head‐To‐Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study , 2012, Journal of cardiovascular electrophysiology.
[22] W. Grimm,et al. Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients , 2005, Pacing and clinical electrophysiology : PACE.
[23] Claudia Stöllberger,et al. Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.
[24] A. Moss,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.
[25] G. Boriani,et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection wind , 2009, European heart journal.
[26] S. Saba,et al. Recent Trends in Utilization of Implantable Cardioverter‐Defibrillators in Survivors of Cardiac Arrest in the United States , 2009, Pacing and clinical electrophysiology : PACE.
[27] M. Hannan,et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. , 2012, JAMA.
[28] D. Mark,et al. Prognostic importance of defibrillator shocks in patients with heart failure. , 2008, The New England journal of medicine.
[29] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[30] Jeroen J. Bax,et al. Risk of Failure of Transvenous Implantable Cardioverter-Defibrillator Leads , 2008, Circulation. Arrhythmia and electrophysiology.
[31] Harlan M Krumholz,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.
[32] David L Hayes,et al. Clinical Predictors of Cardiovascular Implantable Electronic Device‐Related Infective Endocarditis , 2009, Pacing and clinical electrophysiology : PACE.
[33] M. Rosenqvist,et al. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators. , 1998, Circulation.